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Book Reviews
High Dose Rate Brachytherapy - A Textbook
Edited by Subir Nag. New York: Futura Publishing Co. Inc..
1994. 462 pp. 569.00.
Conventional brachytherapy has always been recognised as
an excellent way to deliver a high dose of radiation to the
heart of a tumour but has had the disadvantage that it takes
a long time and involves risk of radiation exposure. Recent
developments in afterloading technology and source design
now make it possible to give a high dose of radiation in a
verv short time without exposure hazard and with the pos-
sibility of optimising dose distribution. This multiauthor
book reviews recent experience in this rapidly growing field
and should be of interest to anyone who has just started or is
about to start high dose rate (HDR) brachytherapy.
Those who search for guidance on dose and fractionation
regimens are not going to find it. because with the exception
of a few sites there is too little experience and insufficient
follow-up on which to base advice.
HDR brachytherapy has an accepted role in the manage-
ment of carcinoma of the bronchus and oesophagus because
it allows rapid safe treatment that cannot readily be given in
any other way. It is also widely used in gynaecological
cancer. but for other sites there are still very few data. Manv
of the clinical chapters describe the individual techniques
used and the results of relatively few patients treated in
selected centres in the USA. They do. however. give useful
details on how to perform the implant. References are plen-
tiful and up to date with many after 1990. but there is little
attempt to place HDR brachytherapy within the context of
other treatments. and many valuable European data have not
been included. The strongest sections are on the new
dosimetry methods that have become available and their
integration with imaging and with dose optimisation. There
is also a very full discussion of the potentially serious issue of
quality assurance.
Most of the criticisms are because the subject is so new
that many of the questions arising from it have yet to be
answered. It is perhaps too soon for a definitive textbook but
the data presented give a good view of the current position.
even though much may change over the next few years.
DV Ash
Fssential OncologM for Health Professionals
EML Haagedoorn. J Oldhoff. W Bender. WD Clarke and
DTh Sleijfer. Van Gorcum: Assen. 1994. 408 pp. Dfl 85.00.
ISBN 902 3229053
This book presents the principles of clinical oncology aimed
at the multidisciplinary teams that are now invariably
involved in cancer care. Details of chemotherapy are not
provided. although side-effects from chemotherapy and
radiotherapy provide a significant morbidity for the
oncologist and generalist. There is a definitive description of
TNM staging. but prognosis is not fully discussed according
to specific subgroups of patients which is important in. for
example, breast cancer. The level is realistically medical
undergraduate rather than postgraduate apart from pro-
viding a very general overview. There is a lack of essential
biological and pathological detail in most chapters. and often
important predisposing factors for cancer development are
summarised too generally. for example as 'genetic' or
environrmental events'. Notable bv their absence are con-
siderations of cancer genetics and genetic counselling.
oncogenes and cytogenetic studies. which accentuates the
old-fashioned feel of the book. The role of tumour markers is
oversimplified. particularly in the management of germ cell
tumours. where much more detail is essential as salvage
treatment may be instituted solely on a raised marker result.
It is a concern that a chapter on cancer and nutrition makes
no mention of temporary total parenteral nutrition (TPN)
and enteral feeding with PEG (percutaneous endoscopic gast-
rostomy) which have had a profound effect on patient man-
agement in the last few years. The patient problems' section
is a little confusing: rather than re-examining general app-
roaches to diagnosis and investigation often 'spot diagnoses'
are mentioned and referral to specialists advised rather than
working through logical management strategies. A glossary
of terms and references for further reading would have been
useful for the non-specialist. 'Learning points' boxes would
allow quicker reference and improve the look of the book as
would more imaginative (and preferably colour) illustrations.
In summary. it is difficult to identif) a target readership for
this book, particularly with competing publications being
more modern in approach and presentation.
Hardev Pandha MRCP
Nick Lemoine MD PhD MRCPath
Endocrine Tumours
Ernest L Mazzafern and Nagib A Samaan. Blackwell
Science: Oxford. 1995. 86pp. £150.00. ISBN 0 865422672
This book certainly fills a gap as endocrine oncology has
tended to be considered as a Cinderella subject in the
oncology field. although past oncologists who have looked
after thyroid and endocrine cancer have included some most
distinguished individuals. This is generally a most excellent
and comprehensive book which covers best the expected
areas. However. I did wonder whether it was really necessary
to try and be all-embracing and include sections on prostate
cancer. testis cancer. germ cell cancers and breast tumours.
These chapters are really only superficially covered and might
better have been omitted altogether and left to a general
oncology textbook or a specialist book. Nevertheless, the
overall impression is of an excellent reference book.
I have not attempted to review the entire book since it is
some 800-odd pages in length and there are several areas that
do not come into my clinical practice. such as pituitary
tumours. I have therefore concentrated on the thyroid.
adrenal. pancreatic and gastrointestinal endocrine cancers
and the carcinoid tumours, which constitute at least two-
thirds of the content of the book.
Thyroid cancer management presents a well-balanced over-
view. putting forward both sides of the arguments in those
areas where there are many and deep controversies. Occas-
sionally the authors' individual prejudices are allowed to
shine through, but nevertheless the balance is generally very
well done. There are plenty of good illustrations. tables and
graphs which are clear and easy to understand. The section is
well referenced and very comprehensive.
Adrenal neoplasms are also covered in depth: particularly
well covered is the area on the work-up and diagnosis of
adrenal neoplasms. although the non-surgical management is
rather poorer. and the coverage of treatment with radionuc-
lides such as ['3I]MIBG and chemotherapy is almost dismis-
sive. It is perhaps unfortunate that an oncologist did not
contribute to this chapter. Furthermore. there is no mention
of the use of indium-labelled octreotide in the diagnostic
section of neuroendocrine tumours. which may represent an
American bias.
Again the section on the gastrointestinal and pancreatic
neuroendocrine cancers is generally well done. although it is